These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17537135)

  • 21. Quality assessment in clinical trials: considerations for outcomes research in interventional pain medicine.
    Hartrick CT
    Pain Pract; 2008; 8(6):433-8. PubMed ID: 18783359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-outcome design for randomized comparative phase II clinical trials.
    Hong S; Wang Y
    Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes.
    Ji Y; Bekele BN
    Biometrics; 2009 Sep; 65(3):876-84. PubMed ID: 19173694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The delayed-start study in Parkinson disease: can't satisfy everyone.
    Olanow CW; Rascol O
    Neurology; 2010 Apr; 74(14):1149-50. PubMed ID: 20368635
    [No Abstract]   [Full Text] [Related]  

  • 27. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are we satisfied with the way we review an article?
    Aslam M; Burris HH; Zupancic JA
    Adv Neonatal Care; 2009 Feb; 9(1):40-2. PubMed ID: 19212165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The principle of parallelism in the design of studies to estimate treatment effects.
    Reichardt CS
    Psychol Methods; 2006 Mar; 11(1):1-18. PubMed ID: 16594764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions.
    Hancock M; Herbert RD; Maher CG
    Phys Ther; 2009 Jul; 89(7):698-704. PubMed ID: 19465372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
    Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
    Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials.
    Yan G; Greene T
    Clin Trials; 2011 Oct; 8(5):571-80. PubMed ID: 22013170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient decision aids to support clinical decision making: evaluating the decision or the outcomes of the decision.
    McCaffery K; Irwig L; Bossuyt P
    Med Decis Making; 2007; 27(5):619-25. PubMed ID: 17873254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.